It’s been a few weeks since the Department of Health and Human Services proposed a new piece of legislation that would force pharmaceutical companies to change the way they discount their products. Check out part 1 of a 3-part podcast series featuring Model N life science industry leaders; Nate Taninecz and Jesse Mendelsohn. Hear their perspective and advice related to safe harbor changes for prescription discounts.